KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka 8-k kineta (17 apr, 11:09am) kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 #ka #8k #kineta #news
Feed of new SEC filings and other useful information for stock market investors.